EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evaluating Renal Disease in Pediatric‐Onset Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome

Kirandeep K Toor, Audrea Chen iD, David A Cabral, Cherry Mammen, Else S Bosman, Ye Shen, Jeffrey N Bone, Damien Noone, Eslam Al-Abadi, Susanne Benseler, Roberta Berard iD, Marek Bohm und 28 weitere

Arthritis & Rheumatology · 2025-05 · 77 (5) · 606-614

DOI: 10.1002/art.43071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 14.01.2025. Verfasst von Kirandeep K Toor und 39 weiteren Autor:innen. Beteiligte Einrichtung: University of British Columbia and BC Children's Hospital and BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Glomerulonephritis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Childhood Arthritis and Rheumatology Research Alliance, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to study the disease course, outcomes, and predictors of outcome in pediatric‐onset antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) affecting the kidneys.

Methods

Patients eligible for this study had a diagnosis of granulomatosis with polyangiitis (GPA), microscopic polyangiitis, or ANCA‐positive pauci‐immune glomerulonephritis, were 18 years or younger at diagnosis, had renal disease defined by biopsy or dialysis dependence, and had clinical data at diagnosis and at either 12 or 24 months. Ambispective data from A Registry for Children with Vasculitis/Pediatric Vasculitis Initiative Registry was used. The primary outcome was inactive renal disease (pediatric vasculitis activity score = 0 or 1) at 12 months. Secondary outcomes included rates of improved renal function and damage within 24 months. Renal function, defined by estimated glomerular filtration rate, was categorized into Kidney Disease Improving Global Outcomes (KDIGO) stages at diagnosis and tested as a predictor of outcome using a proportional‐odds logistic regression model.

Results

A total of 145 patients were included: 68% were female, and 78% had GPA. At 12 months, 83% of patients achieved inactive renal disease; however, 42% had evidence of permanent renal damage. Compared with patients with normal renal function at diagnosis, patients with moderate to severely reduced renal function, or kidney failure at diagnosis, had an odds ratio of 8.62 ( P = 0.002; 95% confidence interval [CI] 2.31–32.1) and 26.3 (P < 0.001; 95% CI 6.32–109), respectively, for being in a non‐normal KDIGO category at 12 months.

Conclusion

The majority of patients with pediatric AAV achieve inactive renal disease by 12 months; however, almost half have evidence of damage. Renal function at diagnosis is a strong predictor of renal function at 12 months. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGlomerulonephritisGranulomatosis with PolyangiitisMicroscopic PolyangiitisKidney DiseasesHumansFemaleMaleChildAdolescentGlomerular Filtration RateChild, PreschoolImmunosuppressive AgentsDisease ProgressionRegistriesSeverity of Illness IndexKidneyLogistic ModelsTreatment Outcome

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • University of British Columbia and BC Children's Hospital and BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • University of British Columbia, Vancouver, British Columbia, Canada.
  • BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Birmingham Children's Hospital NHS Foundation Trust, Birmingham, United Kingdom.
  • Alberta Children's Hospital, Calgary, Alberta, Canada.

ORCID-Profile: Audrea Chen, Roberta Berard, Dirk Foell, Merav Heshin-Bekenstein, Susan Kim, Susan Shenoi, Kelly L Brown

Förderung

  • CIHR
  • Childhood Arthritis and Rheumatology Research Alliance
  • Canadian Institutes of Health Research

Zitieren

APA

Toor, K. K., Chen, A., Cabral, D. A., Mammen, C., Bosman, E. S., Shen, Y., Bone, J. N., Noone, D., Al-Abadi, E., Benseler, S., Berard, R., Bohm, M., Charuvanij, S., Cook, K., Dancey, P., Deepak, S., Duffy, C., Eberhard, B., Elder, M., …, & PedVas Investigators Network (2025). Evaluating Renal Disease in Pediatric‐Onset Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome. Arthritis & Rheumatology, 77(5), 606-614. https://doi.org/10.1002/art.43071

Vancouver

Toor KK, Chen A, Cabral DA, Mammen C, Bosman ES, Shen Y, et al. Evaluating Renal Disease in Pediatric‐Onset Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome. Arthritis & Rheumatology. 2025;77(5):606-614. doi:10.1002/art.43071

BibTeX
@article{Toor2025,
  author = {Toor, Kirandeep K and Chen, Audrea and Cabral, David A and Mammen, Cherry and Bosman, Else S and Shen, Ye and Bone, Jeffrey N and Noone, Damien and Al-Abadi, Eslam and Benseler, Susanne and Berard, Roberta and Bohm, Marek and Charuvanij, Sirirat and Cook, Kathryn and Dancey, Paul and Deepak, Samundeeswari and Duffy, Ciaran and Eberhard, Barbara and Elder, Melissa and Foell, Dirk and Gerstbacher, Dana and Heshin-Bekenstein, Merav and Huber, Adam and James, Karen E and Kim, Susan and Klein-Gitelman, Marisa and Martin, Neil and McErlane, Flora and Moorthy, L Nandini and Myrup, Charlotte and Riley, Phil and Shenoi, Susan and Sivaraman, Vidya and Tanner, Tamara and Tarvin, Stacey and Wagner-Weiner, Linda and Yeung, Rae S M and Brown, Kelly L and Morishita, Kimberly A and PedVas Investigators Network, PedVas Investigators Network},
  title = {Evaluating Renal Disease in Pediatric‐Onset Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  volume = {77},
  number = {5},
  pages = {606--614},
  doi = {10.1002/art.43071}
}
Kostenlos starten →